During the past decade, Baptist Medical Center Montclair conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Baptist Medical Center Montclair" are "Hypertension" (2 trials), "Coronary Artery Disease" (1 trials) and "Sudden Cardiac Death" (1 trials). Many other conditions were trialed in "Baptist Medical Center Montclair" in a lesser frequency.

Most popular intervention types in "Baptist Medical Center Montclair" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "clevidipine" (2 trials), "CGT003 (E2F Duplex Decoy)" (1 trials), "Implantable Cardioverter Defibrillator (ICD), Cardiac Resynchronization Therapy (CRT-D)" (1 trials), "nitroglycerin" (1 trials) and "sodium nitroprusside" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baptist Medical Center Montclair" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Baptist Medical Center Montclair". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Baptist Medical Center Montclair, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Baptist Medical Center Montclair, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".